Bioamber is sold for an undisclosed amount with an upfront payment which means all $ will be in the valuable Bioamber shares in our accounts, and everything is still a possibility with a multiple step transaction , Bioamber has a bioindustrial technology wth a right to license to other industrial chemical companies and it has, in China, Brazil, Thailand etc. Also into pharmaceuticals also with its fda approved bio-sa, how valuable is that?? Of course you know and so does KKR who is also involved https://glasgowwestend.today/technologies-for-bioplastics-market-size-2023-2029-algix-arkema-basf-bioamber-biomatera-biomer-cardia-bioplastics-cerepl/